Serum calprotectin and renal function decline in ANCA-associated vasculitides: a post hoc analysis of MAINRITSAN trial

Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trial

(2023) Rona M Smith et al.   ANNALS OF THE RHEUMATIC DISEASES

Circulating Calprotectin (cCLP) in autoimmune diseases

(2023) Mariangela Manfredi et al.   AUTOIMMUNITY REVIEWS

Combining neutrophil and macrophage biomarkers to detect active disease in ANCA vasculitis: a combinatory model of calprotectin and urine CD163

(2022) Paula Anton-Pampols et al.   Clinical Kidney Journal

Avacopan for the Treatment of ANCA-Associated Vasculitis

(2021) David R.W. Jayne et al.   NEW ENGLAND JOURNAL OF MEDICINE

Danger-associated molecular pattern molecules and the receptor for advanced glycation end products enhance ANCA-induced responses

(2021) Theresa H Page et al.   RHEUMATOLOGY

A cohort study to investigate sex-specific differences in ANCA-associated glomerulonephritis outcomes

(2021) Jennifer Scott et al.   Scientific Reports

Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19

(2020) Aymeric Silvin et al.   CELL

Neutrophil calprotectin identifies severe pulmonary disease in COVID‐19

(2020) Hui Shi et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Long-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

(2020) Pierre Charles et al.   ANNALS OF INTERNAL MEDICINE

Systemic calprotectin and chronic inflammatory rheumatic diseases

(2019) Xavier Romand et al.   JOINT BONE SPINE

Biological variation of measured and estimated glomerular filtration rate in patients with chronic kidney disease

(2019) Ceri Rowe et al.   KIDNEY INTERNATIONAL

Exploring sex-specific differences in the presentation and outcomes of ANCA-associated vasculitis: a nationwide registry-based cohort study

(2018) Rune Bjørneklett et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

Calprotectin as a smoldering activity detection tool and renal prognosis biomarker in ANCA associated vasculitis

(2018) Laura Martinez Valenzuela et al.   PLoS One

Renal relapse in antineutrophil cytoplasmic autoantibody-associated vasculitis: unpredictable, but predictive of renal outcome

(2018) Maria A C Wester Trejo et al.   RHEUMATOLOGY

Development and validation of a renal risk score in ANCA-associated glomerulonephritis

(2018) Silke R. Brix et al.   KIDNEY INTERNATIONAL

Impact of renal involvement on survival in ANCA-associated vasculitis

(2016) Manish Rathi et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

Association of Serum Calprotectin (S100A8/A9) Level With Disease Relapse in Proteinase 3-Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

(2016) Ruth J. Pepper et al.   Arthritis & Rheumatology

S100A8/A9 (Calprotectin) Is Critical for Development of Glomerulonephritis and Promotes Inflammatory Leukocyte–Renal Cell Interactions

(2015) Ruth J. Pepper et al.   AMERICAN JOURNAL OF PATHOLOGY

Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis

(2014) Loïc Guillevin et al.   NEW ENGLAND JOURNAL OF MEDICINE

C5a Receptor (CD88) Blockade Protects against MPO-ANCA GN

(2013) H. Xiao et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Leukocyte and serum S100A8/S100A9 expression reflects disease activity in ANCA-associated vasculitis and glomerulonephritis

(2013) Ruth J. Pepper et al.   KIDNEY INTERNATIONAL

Classification of antineutrophil cytoplasmic autoantibody vasculitides: The role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis

(2012) Sophia Lionaki et al.   ARTHRITIS AND RHEUMATISM

Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis

(2011) Michael Walsh et al.   ARTHRITIS AND RHEUMATISM

Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis--a meta-analysis

(2011) G. Tomasson et al.   RHEUMATOLOGY

Use of Highly Sensitive C-Reactive Protein for Followup of Wegener's Granulomatosis

(2010) A.-I. KALSCH et al.   JOURNAL OF RHEUMATOLOGY